MECOM

MECOM is a transcriptional regulator and oncoprotein that may be involved in hematopoiesis, apoptosis, development, and cell differentiation and proliferation. The encoded protein can interact with CTBP1, SMAD3, CREBBP, KAT2B, MAPK8, and MAPK9. This gene can undergo translocation with the AML1 gene, resulting in overexpression of this gene and the onset of leukemia. Several transcript variants encoding a few different isoforms have been found for this gene.
Full Name
MDS1 and EVI1 complex locus
Function
Isoform 1:
Functions as a transcriptional regulator binding to DNA sequences in the promoter region of target genes and regulating positively or negatively their expression. Oncogene which plays a role in development, cell proliferation and differentiation. May also play a role in apoptosis through regulation of the JNK and TGF-beta signaling. Involved in hematopoiesis.

Isoform 7:
Displays histone methyltransferase activity and monomethylates 'Lys-9' of histone H3 (H3K9me1) in vitro. Probably catalyzes the monomethylation of free histone H3 in the cytoplasm which is then transported to the nucleus and incorporated into nucleosomes where SUV39H methyltransferases use it as a substrate to catalyze histone H3 'Lys-9' trimethylation. Likely to be one of the primary histone methyltransferases along with PRDM16 that direct cytoplasmic H3K9me1 methylation.
Biological Process
Apoptotic process Source: UniProtKB-KW
Cell differentiation Source: UniProtKB-KW
Hematopoietic stem cell proliferation Source: UniProtKB
Heterochromatin organization Source: UniProtKB
Negative regulation of JNK cascade Source: UniProtKB
Negative regulation of programmed cell death Source: UniProtKB
Negative regulation of transcription, DNA-templated Source: UniProtKB
Positive regulation of transcription, DNA-templated Source: UniProtKB
Regulation of cell cycle Source: UniProtKB
Regulation of transcription by RNA polymerase II Source: GO_Central
Cellular Location
Nucleus
Nucleus speckle
Cytoplasm
Involvement in disease
A chromosomal aberration involving EVI1 is a cause of chronic myelogenous leukemia (CML). Translocation t(3;21)(q26;q22) with RUNX1/AML1.
Radioulnar synostosis with amegakaryocytic thrombocytopenia 2 (RUSAT2):
An autosomal dominant disease characterized by proximal fusion of the radius and ulna resulting in extremely limited pronation and supination of the forearm, and congenital thrombocytopenia that progresses to pancytopenia.
A chromosomal aberration involving MDS1 is found in a form of acute myeloid leukemia (AML). Translocation t(3;21) with AML1.
PTM
Phosphorylated.
May be acetylated by CREBBP and KAT2B.
View more

Anti-MECOM antibodies

+ Filters
Loading...
Target: MECOM
Host: Rabbit
Antibody Isotype: IgG
Specificity: Human
Clone: S.446.4
Application*: F, IC, IF, IP, WB
Target: MECOM
Host: Rabbit
Antibody Isotype: IgG
Specificity: Human
Clone: C50E12
Application*: WB, IP, IF (IC), F
Target: MECOM
Host: Mouse
Antibody Isotype: IgG1
Specificity: Human, Mouse
Clone: CBFYM-1987
Application*: WB
Target: MECOM
Host: Mouse
Antibody Isotype: IgG1
Specificity: Human
Clone: CBFYM-1986
Application*: WB
Target: MECOM
Host: Mouse
Antibody Isotype: IgG
Specificity: Human
Clone: CBFYM-1985
Application*: DB, WB
Target: MECOM
Host: Mouse
Antibody Isotype: IgG1, κ
Specificity: Human
Clone: CBFYM-1984
Application*: E, WB
Target: MECOM
Host: Mouse
Antibody Isotype: IgG2b, κ
Specificity: Human
Clone: CBFYM-1982
Application*: WB, E
Target: MECOM
Host: Mouse
Antibody Isotype: IgG2b
Specificity: Human
Clone: CBFYM-1981
Application*: E, IC
Target: MECOM
Host: Mouse
Antibody Isotype: IgG1
Specificity: Human
Clone: CBFYM-0614
Application*: WB
Target: MECOM
Host: Mouse
Antibody Isotype: IgG1, κ
Specificity: Human
Clone: CBFYE-1551
Application*: E, WB
Target: MECOM
Host: Mouse
Antibody Isotype: IgG2b
Specificity: Human
Clone: CBFYE-1550
Application*: IC
Target: MECOM
Host: Mouse
Antibody Isotype: IgG2b
Specificity: Human
Clone: CBFYE-1549
Application*: WB
Target: MECOM
Host: Mouse
Antibody Isotype: IgG
Specificity: Human
Clone: 2331C1a1
Application*: DB
More Infomation
Submit A Review Fig.3 Signaling pathways in cancers. (Creative Biolabs Authorized) Fig.4 Protocols troubleshootings & guides. (Creative Biolabs Authorized) Submit A Review Fig.3 Signaling pathways in cancers. (Creative Biolabs Authorized) Fig.4 Protocols troubleshootings & guides. (Creative Biolabs Authorized)
For Research Use Only. Not For Clinical Use.
(P): Predicted
* Abbreviations
  • AActivation
  • AGAgonist
  • APApoptosis
  • BBlocking
  • BABioassay
  • BIBioimaging
  • CImmunohistochemistry-Frozen Sections
  • CIChromatin Immunoprecipitation
  • CTCytotoxicity
  • CSCostimulation
  • DDepletion
  • DBDot Blot
  • EELISA
  • ECELISA(Cap)
  • EDELISA(Det)
  • ESELISpot
  • EMElectron Microscopy
  • FFlow Cytometry
  • FNFunction Assay
  • GSGel Supershift
  • IInhibition
  • IAEnzyme Immunoassay
  • ICImmunocytochemistry
  • IDImmunodiffusion
  • IEImmunoelectrophoresis
  • IFImmunofluorescence
  • IHImmunohistochemistry
  • IMImmunomicroscopy
  • IOImmunoassay
  • IPImmunoprecipitation
  • ISIntracellular Staining for Flow Cytometry
  • LALuminex Assay
  • LFLateral Flow Immunoassay
  • MMicroarray
  • MCMass Cytometry/CyTOF
  • MDMeDIP
  • MSElectrophoretic Mobility Shift Assay
  • NNeutralization
  • PImmunohistologyp-Paraffin Sections
  • PAPeptide Array
  • PEPeptide ELISA
  • PLProximity Ligation Assay
  • RRadioimmunoassay
  • SStimulation
  • SESandwich ELISA
  • SHIn situ hybridization
  • TCTissue Culture
  • WBWestern Blot
online inquiry
Online Inquiry